Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Genetics and genomics are increasingly in the news. People can buy genetic tests on the internet, without providing a medical reason or involving a health professional. But how useful is personal genetic health information, and are there any downsides to buying tests?

23andMe personal genetic test saliva collection kit, with tube, box and instructions

An Oxford Science Blog written by Dr Liz Ormondroyd

I am a researcher in the Radcliffe Department of Medicine at the University of Oxford, and a genetic counsellor working with patients with inherited cardiac disease and their families. I see at first hand the benefits of genetic testing in the NHS, but also the variety of questions people want to discuss before going ahead with a test.

Buying a ‘direct to consumer’; (DTC) genetic test is different from an NHS genetic test in many ways, so when the UK Parliament announced an inquiry into Commercial genomics in 2019, I submitted written evidence along with many health professionals and academics, commercial providers and other interested parties.

The ‘Research & Public Policy Partnership’ scheme opened in late 2019 and seemed a good opportunity to start to build a programme of research that would have policy input from the start, ensuring its relevance for policy. The University Policy Engagement Team suggested approaching Dr Peter Border at the Parliamentary Office of Science and Technology (POST).  Together with a General Practice and ethicist colleague, Dr Andrew Papanikitas, we put together a proposal outlining how we would work together and what we wanted to achieve.

Read the full blog on the University of Oxford website.

Similar stories

Tackling suicide risk in people with mental disorders

Clinical researchers from Oxford University’s Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients at risk of suicide.

Environmental impact of 57,000 multi-ingredient processed foods revealed

A study estimating the environmental impact of 57,000 food products in the UK and Ireland has been published by an Oxford-led research team in the journal PNAS.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.

DPAG hosts successful first Science in the Park event

More than 100 children, along with around 50 parents, grandparents and caregivers enjoyed an exciting variety of activities on the theme of ‘How the Body Works’ in University Parks on Tuesday 26 July. This ‘Science in the Park’ event was run by the Department of Physiology, Anatomy & Genetics (DPAG) Outreach and Public Engagement Working Group (OPEWG) and volunteers comprising research scientists, clinical anatomy teaching staff, and graduate and undergraduate students.

Viral role in Alzheimer's Disease discovered

Researchers from Oxford’s Institute of Population Ageing, Tufts University and the University of Manchester have discovered that common viruses appear to play a role in some cases of Alzheimer’s disease (AD).